The post Crypto News: Whales Hedge Positions With Based Eggman ($GGs) Presale, Ethereum Drops Toward $4,400 appeared first on Coinpedia Fintech News The crypto market is seeing sharp movements once again, with Ethereum sliding toward $4,400 after testing recent highs. Traders and whales are adjusting their positions to manage risk and capture new opportunities. One of the growing strategies involves diversifying into token presales. These early-stage offerings allow investors to secure tokens at fixed rates before full …The post Crypto News: Whales Hedge Positions With Based Eggman ($GGs) Presale, Ethereum Drops Toward $4,400 appeared first on Coinpedia Fintech News The crypto market is seeing sharp movements once again, with Ethereum sliding toward $4,400 after testing recent highs. Traders and whales are adjusting their positions to manage risk and capture new opportunities. One of the growing strategies involves diversifying into token presales. These early-stage offerings allow investors to secure tokens at fixed rates before full …

Crypto News: Whales Hedge Positions With Based Eggman ($GGs) Presale, Ethereum Drops Toward $4,400

2025/09/16 21:59
4 min read
based-eggman

The post Crypto News: Whales Hedge Positions With Based Eggman ($GGs) Presale, Ethereum Drops Toward $4,400 appeared first on Coinpedia Fintech News

The crypto market is seeing sharp movements once again, with Ethereum sliding toward $4,400 after testing recent highs. Traders and whales are adjusting their positions to manage risk and capture new opportunities.

One of the growing strategies involves diversifying into token presales. These early-stage offerings allow investors to secure tokens at fixed rates before full listings. Based Eggman ($GGs) has emerged as one of the best crypto presales to buy right now, drawing attention from both retail buyers and large holders.

This shows how crypto presale projects are influencing wider market behavior alongside established assets.

based-eggman

Based Eggman ($GGs): Gaming Meets Presale Crypto

Based Eggman ($GGs) is shaping up as one of the top crypto presales in 2025. Built on Base, Coinbase’s Layer 2, it combines meme energy with real-world gaming infrastructure. 

Unlike many presale crypto tokens that focus only on trading, $GGs connects players, streamers, and communities in a unified ecosystem.

The project allows users to log in with simple accounts, play short games, and earn GGs tokens without complicated onboarding. 

Every interaction in its social gaming network adds value, from sharing memes to joining competitive events. With over $110,135 USDT raised and 14 million tokens sold, the presale coin has already captured notable interest.

Each $GGs token is priced at $0.006389, positioning it within reach for those looking to buy presale crypto. Its cultural foundation also sets it apart. The phrase “GGs,” meaning “good game,” is already familiar to millions of gamers. This makes the project instantly relatable while still being part of the broader web3 crypto presale movement.

Ethereum: Current Price and Predictions

Ethereum recently touched $4,461, setting a fresh high before retracing toward $4,400. It continues to hold a central role in decentralized applications, NFTs, and smart contracts, with strong institutional interest driving momentum.

Some market analysts project higher long-term valuations, linking Ethereum’s growth to ETF inflows and adoption among companies holding crypto in their treasuries. At the same time, Ethereum’s volatility keeps traders active, with many balancing positions across both established coins and presale crypto coins.

While forecasts differ, Ethereum remains an anchor in discussions about cryptocurrency presales, as it sets the standard for what blockchain projects can achieve.

Market Moves: Whales Turn to Based Eggman ($GGs)

Recent market news shows whales diversifying their portfolios by entering the Based Eggman $GGs presale. This trend emerged as Ethereum’s price edged toward $4,400, sparking hedging strategies across major holders.

By participating in presale crypto, whales are not abandoning Ethereum but are seeking balance with new token presales that carry cultural and gaming appeal. Based Eggman is attracting this attention because it combines practical gaming use cases with meme identity, something that resonates across communities.

This reflects a broader reality of the crypto market. Token presales, such as $GGs, offer a chance to enter at lower fixed prices while still supporting projects that connect directly with Web3 culture and technology.

Comparison Table: $GGs vs Ethereum

Feature$GGs (Based Eggman)Ethereum (ETH)
BlockchainBase (L2)Ethereum mainnet
Presale AvailabilityYesNo
Current Price$0.006389$4,400+
Use CaseGaming + Streaming + MemeSmart Contracts + DeFi
Community AppealGamers + Meme CultureGlobal Developers + DeFi

Conclusion: Presales Shape the Broader Market Story

The crypto market thrives on both tradition and innovation. Ethereum represents the established foundation, while new crypto presales like Based Eggman ($GGs) inject cultural momentum and accessible entry points. Together, they form a balanced picture of how investors navigate 2025.

Presale crypto tokens are no longer viewed as side projects. They now play a role in how whales and retail investors manage their positions during volatile swings. Based Eggman is part of this movement, showing that a presale coin can merge gaming, streaming, and trading into one ecosystem.

For those reviewing the crypto presale list, $GGs stands out as one of the best crypto presales to buy right now, reflecting how token presales and established giants like Ethereum continue to shape the industry side by side.

More Information on Based Eggman Presale Here:  

Website: https://basedeggman.com/

X (Twitter): https://x.com/Based_Eggman

Telegram: https://t.me/basedeggman

Market Opportunity
TokenFi Logo
TokenFi Price(TOKEN)
$0,003239
$0,003239$0,003239
-0,39%
USD
TokenFi (TOKEN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26